QT Interval Prolongation in Patients Treated for COVID-19
Habibzadeh, P.; Sarami, A.; Yadollahie, M.; Hashemiasl, K.; Salahi, A.; Habibzadeh, F.
Show abstract
BackgroundMany of the drugs commonly used for the treatment of COVID-19 cause QT interval prolongation and increase the risk of life-threatening cardiac arrhythmias. It has been shown that maintaining serum potassium and magnesium levels above 4 and 3 mg/dL, respectively, would prevent the QTc prolongation. ObjectiveTo determine if keeping only the serum magnesium level above 3 mg/dL could be considered an effective measure to prevent QTc prolongation in patients with COVID-19 receiving these drugs. MethodsIn a retrograde observational study, QTc interval was measured in 14 patients diagnosed with COVID-19 before and 3 days after initiation of treatment with either hydroxychloroquine or lopinavir-ritonavir, while their serum magnesium levels were kept [≥]3 mg/dL. ResultsThe baseline QTc interval of 412 (SD 36) ms significantly increased by an average of 34 (95% CI 13 to 55) ms after 3 days of treatment. 5 patients, mostly those with lower serum potassium levels, had QTc prolongation [≥]60 ms. ConclusionAlthough it seems that the risk of fatal cardiac arrhythmias in this setting is not high, it is prudent to monitor the serum electrolytes, particularly potassium, in patients with COVID-19 who are treated with either hydroxychloroquine or lopinavir-ritonavir.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Impact of vaccination and risk factors on COVID-19 mortality amid delta wave in Libya: a single centre cohort study 94%
- Coagulation abnormalities in children with uncorrected congenital heart defects seen at a teaching hospital in a developing country 93%
- Prevalence, characteristics, and predictors of Long COVID among diagnosed cases of COVID-19 93%
Similar papers in this journal
- Impact of Losartan on Portal hypertension and Liver Cirrhosis: A Systematic Review 94%
- Influence of Factor V Leiden mutation and Protein C/S deficiencies on preeclampsia among Sudanese women 94%
- Comparison of Efficacy of Dexamethasone and Methylprednisolone in Improving the Partial Pressure of Arterial Oxygen and Fraction of Inspired Oxygen Ratio among COVID-19 Patients 93%
Similar papers in this journal
Similar papers in this journal
- Patients at risk of pulmonary fibrosis Post Covid-19: Epidemiology, pulmonary sequelaes and humoral response 90%
- The SARS-CoV-2 cellular receptor ACE2 is expressed in oropharyngeal cells and is modulated in vitro by the bacterial lysate Lantigen B 90%
- Normalized Semi-Covariance Co-Efficiency Analysis of Spike Proteins from SARS-CoV-2 variant Omicron and Other Coronaviruses for their Infectivity and Virulence 89%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.